‘This change in policy will kill’: Experts troubled by CDC changes to COVID-19 testing guidelines

  • USA Today | by: Adrianna Rodriguez |
  • 08/26/2020 12:00 AM
‘This change in policy will kill’: Experts troubled by CDC changes to COVID-19 testing guidelines
Photo Credit: Tami Chappell/Reuters

The CDC estimates in its COVID-19 Pandemic Planning Scenarios that 40% of infections are asymptomatic and 50% of transmissions occur before symptoms appear. Experts worry that failing to test asymptomatic carriers could not only result in more infections but also hinder contact tracing efforts.

“If being in close personal contact with an infected person … isn’t sufficiently important enough to get tested, I don’t see that there’s any value in contact tracing,” said Peter Pitts, president of the nonprofit Center for Medicine in the Public Interest.

A spokesperson at the U.S. Department of Health and Human Services told CNN the change wouldn’t “undermine contact tracing or any other types of surveillance testing.”

Though Pitts said the change in CDC guidelines “is not permission to do away with testing,” he’s worried that some may take it that way. He said the agency should  encourage more testing.

 
Sign Up for Our Email Newsletter

RECENT NEWS

The Spreading Cancer of Counterfeit Drugs
  • CMPI
  • 10/01/2020 12:00 AM

The Spreading Cancer of Counterfeit Drugs

Just as the coronavirus mutates to survive and thrive, so to do the purveyors of counterfeit medicines -- with their high...  Read more

$40 price tag for potential coronavirus vaccine seems to be ‘right on the money,’ says think tank

$40 price tag for potential coronavirus vaccine seems to be ‘right on the money,’ says think tank

If a potential coronavirus vaccine is not affordable, too many people will not get vaccinated, says Peter Pitts, presiden...  Read more

Former FDA Associate Commissioner Says FDA Made Right Move to Authorize Convalescent Plasma

Former FDA Associate Commissioner Says FDA Made Right Move to Authorize Convalescent Plasma

Peter Pitts, President for the Center For Medicine in the Public Interest, explains why he believes the FDA authorized th...  Read more

DRUGWONKS BLOG